Prestige Consumer Healthcare Inc
PBH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$32.00 | Crmsln | Djnrbybc |
Prestige Healthcare Earnings: Strong International Sales Offset Weak North America Performance
Prestige Consumer Healthcare reported third-quarter earnings that came in slightly higher than our expectations. Total sales were up 2.6% year over year as robust growth in the international segment proved more than enough to offset a slightly weak North America segment. After updating our model, we are maintaining our fair value estimate of $68.